학술논문
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3years of treatment in randomized phase III trials
Document Type
Article
Author
Source
In: British Journal of Dermatology . (British Journal of Dermatology, April 2024, 190(4):477-485)
Subject
Language
English
ISSN
13652133
00070963
00070963